Angiotensin ii-converting enzyme inhibition improves survival, ventricular remodeling, and myocardial energetics in experimental aortic regurgitation

Circulation: Heart Failure

Volumn 6, Issue 5, 2013, Pages 1021-1028

  Arsenault, Marie ^a   Zendaoui, Adnane ^a   Roussel, Élise ^a   Drolet, Marie Claude ^a   Dhahri, Wahiba ^a   Grenier, Audrey ^a   Gascon, Suzanne ^b   Sarrhini, Otman ^b   Rousseau, Jacques A ^b   Lecomte, Roger ^b   Couet, Jacques ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Aortic valve insufficiency; Captopril; Heart ventricles; Hypertrophy; Metabolism; Volume overload

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; CAPTOPRIL; CARNITINE PALMITOYLTRANSFERASE; CITRATE SYNTHASE; COENZYME A; DIPEPTIDYL CARBOXYPEPTIDASE; G PROTEIN RECEPTOR KINASE 5; GUANINE NUCLEOTIDE BINDING PROTEIN; HEXOKINASE; MALONYL COENZYME A DECARBOXYLASE; OXIDOREDUCTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA VALVE REGURGITATION; ARTICLE; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; DRUG EFFICACY; ENERGY METABOLISM; ENERGY TRANSFER; ENZYME ACTIVITY; ENZYME INHIBITION; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; GENE EXPRESSION; HEART CYCLE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE METABOLISM; HEART VENTRICLE REMODELING; LONG TERM CARE; METABOLISM; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; SUDDEN DEATH; SURVIVAL;

AORTIC VALVE INSUFFICIENCY; CAPTOPRIL; HEART VENTRICLES; HYPERTROPHY; METABOLISM; VOLUME OVERLOAD;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; AORTIC VALVE INSUFFICIENCY; CAPTOPRIL; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; ENERGY METABOLISM; EXTRACELLULAR MATRIX; FATTY ACIDS; G-PROTEIN-COUPLED RECEPTOR KINASE 5; HYPERTROPHY, LEFT VENTRICULAR; MYOCARDIUM; POSITRON-EMISSION TOMOGRAPHY; PROTO-ONCOGENE PROTEINS C-AKT; RATS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84887494501     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.112.000045     Document Type: Article

References (33)

1. Bonow RO, Carabello BA, Kanu C, de Leon AC, Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC, Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Nishimura R, Page RL, Riegel B. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease): Developed in collaboration with the society of cardiovascular anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. 2006;114:e84-e231.
2. Evangelista A, Tornos P, Sambola A, Permayer-Miralda G. Role of vasodilators in regurgitant valve disease. Curr Treat Options Cardiovasc Med. 2006;8:428-434.
3. Scognamiglio R, Negut C, Palisi M, Fasoli G, Dalla-Volta S. Long-term survival and functional results after aortic valve replacement in asymptomatic patients with chronic severe aortic regurgitation and left ventricular dysfunction. J Am Coll Cardiol. 2005;45:1025-1030.
4. Mahajerin A, Gurm HS, Tsai TT, Chan PS, Nallamothu BK. Vasodilator therapy in patients with aortic insufficiency: a systematic review. Am Heart J. 2007;153:454-461.
5. Plante E, Gaudreau M, Lachance D, Drolet MC, Roussel E, Gauthier C, Lapointe E, Arsenault M, Couet J. Angiotensin-converting enzyme inhibitor captopril prevents volume overload cardiomyopathy in experimental chronic aortic valve regurgitation. Can J Physiol Pharmacol. 2004;82:191-199.
6. Plante E, Lachance D, Beaudoin J, Champetier S, Roussel E, Arsenault M, Couet J. Comparative study of vasodilators in an animal model of chronic volume overload caused by severe aortic regurgitation. Circ Heart Fail. 2009;2:25-32.
7. Arsenault M, Plante E, Drolet MC, Couet J. Experimental aortic regurgitation in rats under echocardiographic guidance. J Heart Valve Dis. 2002;11:128-134.
8. Plante E, Couet J, Gaudreau M, Dumas MP, Drolet MC, Arsenault M. Left ventricular response to sustained volume overload from chronic aortic valve regurgitation in rats. J Card Fail. 2003;9:128-140.
9. Couet J, Gaudreau M, Lachance D, Plante E, Roussel E, Drolet MC, Arsenault M. Treatment of combined aortic regurgitation and systemic hypertension: insights from an animal model study. Am J Hypertens. 2006;19:843-850.
10. Plante E, Lachance D, Roussel E, Drolet MC, Arsenault M, Couet J. Impact of anesthesia on echocardiographic evaluation of systolic and diastolic function in rats. J Am Soc Echocardiogr. 2006;19:1520-1525.
11. Croteau E, Gascon S, Bentourkia M, Langlois R, Rousseau JA, Lecomte R, Bénard F. [11C]Acetate rest-stress protocol to assess myocardial perfusion and oxygen consumption reserve in a model of congestive heart failure in rats. Nucl Med Biol. 2012;39:287-294.
12. Ménard SL, Croteau E, Sarrhini O, Gélinas R, Brassard P, Ouellet R, Bentourkia M, van Lier JE, Des Rosiers C, Lecomte R, Carpentier AC. Abnormal in vivo myocardial energy substrate uptake in diet-induced type 2 diabetic cardiomyopathy in rats. Am J Physiol Endocrinol Metab. 2010;298:E1049-E1057.
13. Ménard SL, Ci X, Frisch F, Normand-Lauzière F, Cadorette J, Ouellet R, Van Lier JE, Bénard F, Bentourkia M, Lecomte R, Carpentier AC. Mechanism of reduced myocardial glucose use during acute hypertriglyceridemia in rats. Mol Imaging Biol. 2009;11:6-14.
14. Croteau E, Bénard F, Cadorette J, Gauthier ME, Aliaga A, Bentourkia M, Lecomte R. Quantitative gated PET for the assessment of left ventricular function in small animals. J Nucl Med. 2003;44:1655-1661.
15. Ci X, Frisch F, Lavoie F, Germain P, Lecomte R, van Lier JE, Bénard F, Carpentier AC. The effect of insulin on the intracellular distribution of 14(R,S)-[18F]Fluoro-6-thia-heptadecanoic acid in rats. Mol Imaging Biol. 2006;8:237-244.
16. Bouchard-Thomassin AA, Lachance D, Drolet MC, Couet J, Arsenault M. A high-fructose diet worsens eccentric left ventricular hypertrophy in experimental volume overload. Am J Physiol Heart Circ Physiol. 2011;300:H125-H134.
17. Dhahri W, Couet J, Roussel É, Drolet MC, Arsenault M. Fenofibrate reduces cardiac remodeling and improves cardiac function in a rat model of severe left ventricle volume overload. Life Sci. 2013;92:26-34.
18. Champetier S, Bojmehrani A, Beaudoin J, Lachance D, Plante E, Roussel E, Couet J, Arsenault M. Gene profiling of left ventricle eccentric hypertrophy in aortic regurgitation in rats: rationale for targeting the beta-adrenergic and renin-angiotensin systems. Am J Physiol Heart Circ Physiol. 2009;296:H669-H677.
19. Plante E, Lachance D, Gaudreau M, Drolet MC, Roussel E, Arsenault M, Couet J. Effectiveness of beta-blockade in experimental chronic aortic regurgitation. Circulation. 2004;110:1477-1483.
20. Pitcher JA, Freedman NJ, Lefkowitz RJ. G protein-coupled receptor kinases. Annu Rev Biochem. 1998;67:653-692.
21. Huang ZM, Gold JI, Koch WJ. G protein-coupled receptor kinases in normal and failing myocardium. Front Biosci. 2011;16:3047-3060.
22. Lachance D, Plante E, Bouchard-Thomassin AA, Champetier S, Roussel E, Drolet MC, Arsenault M, Couet J. Moderate exercise training improves survival and ventricular remodeling in an animal model of left ventricular volume overload. Circ Heart Fail. 2009;2:437-445.
23. Shah RM, Singh M, Bhuriya R, Molnar J, Arora RR, Khosla S. Favorable effects of vasodilators on left ventricular remodeling in asymptomatic patients with chronic moderate-severe aortic regurgitation and normal ejection fraction: a meta-analysis of clinical trials. Clin Cardiol. 2012;35:619-625.
24. Evangelista A, Tornos P, Sambola A, Permanyer-Miralda G, Soler-Soler J. Long-term vasodilator therapy in patients with severe aortic regurgitation. N Engl J Med. 2005;353:1342-1349.
25. Dhahri W, Roussel E, Drolet MC, Gascon S, Sarrhini O, Rousseau JA, Lecomte R, Couet J, Arsenault M. Metformin reduces left ventricular eccentric re-modeling in experimental volume overload in the rat. J Clin Exp Cardiolog. 2012;13:8.
26. Pfeffer JM, Pfeffer MA, Mirsky I, Braunwald E. Prevention of the development of heart failure and the regression of cardiac hypertrophy by captopril in the spontaneously hypertensive rat. Eur Heart J. 1983;(4 suppl A):143-148.
27. Pfeffer JM, Pfeffer MA, Mirsky I, Braunwald E. Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat. Proc Natl Acad Sci USA. 1982;79:3310-3314.
28. Pellieux C, Aasum E, Larsen TS, Montessuit C, Papageorgiou I, Pedrazzini T, Lerch R. Overexpression of angiotensinogen in the myocardium induces downregulation of the fatty acid oxidation pathway. J Mol Cell Cardiol. 2006;41:459-466.
29. Pellieux C, Montessuit C, Papageorgiou I, Lerch R. Angiotensin II downregulates the fatty acid oxidation pathway in adult rat cardiomyocytes via release of tumour necrosis factor-alpha. Cardiovasc Res. 2009;82:341-350.
30. Brancaccio M, Hirsch E, Notte A, Selvetella G, Lembo G, Tarone G. Integrin signalling: the tug-of-war in heart hypertrophy. Cardiovasc Res. 2006;70:422-433.
31. Sugden PH. Signaling pathways activated by vasoactive peptides in the cardiac myocyte and their role in myocardial pathologies. J Card Fail. 2002;8(suppl 6):S359-S369.
32. Cook SA, Matsui T, Li L, Rosenzweig A. Transcriptional effects of chronic Akt activation in the heart. J Biol Chem. 2002;277:22528-22533.
33. Martini JS, Raake P, Vinge LE, DeGeorge BR Jr, DeGeorge B Jr, Chuprun JK, Harris DM, Gao E, Eckhart AD, Pitcher JA, Koch WJ. Uncovering G protein-coupled receptor kinase-5 as a histone deacetylase kinase in the nucleus of cardiomyocytes. Proc Natl Acad Sci USA. 2008;105:12457-12462.